Citations

Clear

8 citation(s) found for "Grossman, Ashley".

Consensus on biomarker utility for ACTH-dependent Cushing syndrome: a Pituitary Society Modified Delphi Panel
Fleseriu, Maria , Biller, Beverly M. K. , Reincke, Martín , Мелмед, Шломо , Group, the Pituitary Society International Cushing Syndrome Delphi Panel Consensus, Akirov, Amit , Araki, Takako, Auchus, Richard, Ben-Shlomo, Anat , Bertherat, Jérôme, Biermasz, Nienke R, Castinetti, Frédéric, Ceccato, Filippo, Christ-Crain, Mirjam, Feelders, Richard A. , Findling, James W. , Gadelha, Monica, Geer, Eliza B, Giustina, Andrea, Grossman, Ashley, Gurnell, Mark, Hanzu, Felicia, Hinojosa-Amaya, Jose M, Isand, Kristina , Isidori, Andrea M, Kadioğlu, Pinar, Karavitaki, Niki, McCormack, A I, Nieman, Lynnette, Nowak, Elisabeth, Pivonello, Rosario, Salvatori, Roberto , Stewart, Paul M., Tabarin, Antoine, Takahashi, Yutaka, Theodoropoulou, Marily , Valassi, Elena, Varlamov, Elena V , Walia, Rama, Wass, John, Cheung, Cassandra, Priven, Mariel , Brown, Marielle, Biller, Beverly M K , Bancos, Irina , Fukuoka, Hidenori , Reincke, Martin , Newell-Price, John , Melmed, Shlomo , Bancos, Irina , Newell‐Price, John , Bertherat, Jérôme , Bidlingmaier, Martin , Biermasz, Nienke Ruurdje , Castinetti, Frédéric , Ceccato, Filippo , Christ‐Crain, Mirjam , Gadelha, Mônica R. , Geer, Eliza B. , Glezer, Andréa , Giustina, Andrea , Greenman, Yona , Grossman, Ashley, Gurnell, Mark , Hanzu, Felicia Alexandra , Hinojosa‐Amaya, José Miguel , Isidori, Andrea M. , Kadıoğlu, Pınar , Karavitaki, Niki , Langlois, Fabienne , Nieman, Lynnette K. , Nowak, Elisabeth , Pereira, Alberto M. , Petersenn, Stephan , Pivonello, Rosario , Tabarin, Antoine , Valassi, Elena , Vila, Greisa , Brown, Marielle, Fleseriu, Maria

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | July 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1210/clinem/dgag279 | PMID 42460773 Get It

Abstract Context Biochemical test results are central to clinical decision-making for the diagnosis and management of Cushing syndrome (CS). With emerging research and increasing availability of different tests, updated consensus on the utility of these biomarkers is warranted. Objective To establish an updated consensus on the role of biomarkers in the diagnosis and monitoring of adrenocorticotropic hormone-dependent CS, address novel therapeutic approaches, and identify areas for future research. Design A modified 2-round Delphi panel was conducted. Consensus was defined as ≥70% agreement/disagreement for Likert-scale statements or ≥70% selection of the same option for single-choice questions. Setting Participants represented a range of international expertise. Participants Forty-one participants took part in the Delphi panel, with no attrition between rounds (one nonclinician was not required to complete the second round). An 8-member Steering Committee guided statement development. Results Of statements designed to reach consensus, 45% (14/31) and 44% (11/25) statements reached consensus in Rounds 1 and 2, respectively. Notably, most panelists reported the use of late-night salivary cortisol for diagnosis of mild CS and for monitoring following pituitary surgery or medical or radiation therapy. Most panelists responded that block-and-replace therapies can be considered in patients with cyclical or severe CS, and consensus was reached that restoration of circadian rhythm is a treatment goal for patients with CS. Conclusion Areas of alignment among experts on the diagnosis and monitoring of CS are presented. The findings from this study are intended to support clinicians in their clinical decision-making and highlight priority areas for future research.
Optimizing pediatric periprocedural pain management part II—Adjunct therapies to support the use of infiltrative anesthetics
Henkel, Emily , Haller, Courtney N. , Diaz, Lucia Z., Ricles, Victoria , Grossman, Ashley V. Wong, Krakowski, Andrew C. , Wong Grossman, Ashley V, Nemergut, Michael E. , Grossman, Ashley Wong

Mayo Clinic

Pediatric Dermatology | July 5, 2024 | Volume: 41 | Issue: 4 | Pages: 588-598

10.1111/pde.15677 | PMID 38965874 Get It

AbstractPediatric procedure‐related pain management is often incompletely understood, inadequately addressed, and critical in influencing a child's lifelong relationship with the larger healthcare community. We present a comprehensive review of infiltrative anesthetics, including a comparison of their mechanisms of action and relative safety and efficacy data to help guide clinical selection. We also describe the multimodal utilization of adjunct therapies—in series and in parallel—to support the optimization of pediatric periprocedural pain management, enhance the patient experience, and provide alternatives to sedation medication and general anesthesia.
Optimizing pediatric periprocedural pain management part I—Evolving ethics and topical anesthetics
Henkel, Emily , Haller, Courtney N. , Diaz, Lucia Z., Ricles, Victoria , Grossman, Ashley V. Wong, Krakowski, Andrew C. , Wong Grossman, Ashley V, Nemergut, Michael E. , Grossman, Ashley Wong

Mayo Clinic

Pediatric Dermatology | May 14, 2024 | Volume: 41 | Issue: 4 | Pages: 577-587

10.1111/pde.15635 | PMID 38743586 Get It

AbstractPediatric procedure‐related pain management is often incompletely understood, inadequately addressed, and critical in influencing a child's lifelong relationship with the larger health care community. We highlight the evolution of ethics and expectations around optimizing periprocedural pain management as a fundamental human right. We investigate the state‐of‐the‐art of topical anesthetics, reviewing their mechanisms of action and providing comparisons of their relative safety and efficacy data to help guide clinical selection. In total, this two‐part review offers a combination of conventional approaches and innovative techniques that should be used multimodally—in series and in parallel—to help optimize pain management and provide alternatives to sedation medication and general anesthesia.
1159: UNANTICIPATED AIRWAY DECOMPENSATION AFTER A MINOR FALL
Grossman, Ashley Wong, Grossman, Daniel , McGuire, Sarayna S. , Grossman, Daniel

Mayo Clinic

Critical Care Medicine | December 15, 2022 | Volume: 51 | Issue: 1 | Pages: 578-578

10.1097/01.ccm.0000910372.87023.0d Get It

1183: SUCCESSFUL PEDIATRIC MASK VENTILATION IN EPIDERMOLYSIS BULLOSA
Thalji, Leanne, Grossman, Ashley Wong

Mayo Clinic

Critical Care Medicine | December 16, 2021 | Volume: 50 | Issue: 1 | Pages: 590-590

10.1097/01.ccm.0000811056.85298.45 Get It

Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations
Reincke, Martín , Assié, Guillaume , Buchfelder, Michael , Ceccato, Filippo , Daniele, Andrea, Detomas, Mario , Dalmazi, Guido Di , Findling, James W. , Grossman, Ashley , Gomez-Sanchez, Celso E, Heaney, Anthony P. , Honegger, J. , Laws, Edward R. , Murakami, Masanori , Newell‐Price, John , Giraldi, Francesca Pecori , Perez‐Rivas, Luis Gustavo , Rainey, William E. , Schopohl, Jochen , Theodoropoulou, Marily , Rossum, Elisabeth F. C. van , Zacharieva, Sabina , Ritzel, Katrin , Ceccato, Filippo , Karavitaki, Niki , Lacroix, Andre , Pecori Giraldi, Francesca , Newell-Price, John , Murakami, Masanori , Albani, Adriana , Bancos, Irina , Brue, Thierry Christian , Chabre, Olivier , Elenkova, Atanaska P. , Karavitaki, Niki , Lacroix, André , Losa, Marco , Pivonello, Rosario , Sbiera, Silviu , Stratakis, Constantine A. , Valassi, Elena , Rubinstein, German

Mayo Clinic

European Journal of Endocrinology | January 12, 2021 | Volume: 184 | Issue: 3 | Pages: P1-P16

10.1530/eje-20-1088 | PMID 33444221 Get It

Background Corticotroph tumor progression (CTP) leading to Nelson’s syndrome (NS) is a severe and difficult-to-treat complication subsequent to bilateral adrenalectomy (BADX) for Cushing’s disease. Its characteristics are not well described, and consensus recommendations for diagnosis and treatment are missing. Methods A systematic literature search was performed focusing on clinical studies and case series (≥5 patients). Definition, cumulative incidence, treatment and long-term outcomes of CTP/NS after BADX were analyzed using descriptive statistics. The results were presented and discussed at an interdisciplinary consensus workshop attended by international pituitary experts in Munich on October 28, 2018. Results Data covered definition and cumulative incidence (34 studies, 1275 patients), surgical outcome (12 studies, 187 patients), outcome of radiation therapy (21 studies, 273 patients), and medical therapy (15 studies, 72 patients). Conclusions We endorse the definition of CTP-BADX/NS as radiological progression or new detection of a pituitary tumor on thin-section MRI. We recommend surveillance by MRI after 3 months and every 12 months for the first 3 years after BADX. Subsequently, we suggest clinical evaluation every 12 months and MRI at increasing intervals every 2–4 years (depending on ACTH and clinical parameters). We recommend pituitary surgery as first-line therapy in patients with CTP-BADX/NS. Surgery should be performed before extrasellar expansion of the tumor to obtain complete and long-term remission. Conventional radiotherapy or stereotactic radiosurgery should be utilized as second-line treatment for remnant tumor tissue showing extrasellar extension
Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
Cryer, Philip E., Axelrod, Lloyd, Grossman, Ashley , Heller, Simon , Montori, Víctor M. , Service, F. John, Seaquist, Elizabeth R. , Montori, Victor M

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 16, 2008 | Volume: 94 | Issue: 3 | Pages: 709-728

10.1210/jc.2008-1410 | PMID 19088155 Get It